Algo version: 0.98b
Kaken Pharmaceutical Co is listed at the PNK Exchange
Kaken Pharmaceutical Co [KKPCF]
PNK Sector: Healthcare Industry:Drug Manufacturers Specialty Generic

Is Kaken Pharmaceutical Co stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Kaken Pharmaceutical Co pays dividends. Last time was Sunday 1st of June 2025 where the investors holding the stock on Friday 28th of March 2025 were paid $0.48248 per share. Over the last 8 times between 2021 and 2025, Kaken Pharmaceutical Co has paid $4.37543 with an average of $0.55 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Kaken Pharmaceutical Co 10 years ago, but if you had invested on Wednesday 9th of December 2020 when the price was $36.80, you would have made a loss of $-12.79 per share or -34.76%

No, the average daily trading liquidity for Kaken Pharmaceutical Co is $29 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Kaken Pharmaceutical Co has no real debt, which is good in periods of high inflation. Kaken Pharmaceutical Co has a good net profit margin of 10.15% and should have high tolerances against inflation.

We have calculated the inflation risk for Kaken Pharmaceutical Co to be low [0.4 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.